MagnetisMM-3: Long-term update and efficacy and safety of less frequent dosing of elranatamab in patients with relapsed or refractory multiple myeloma Meeting Abstract
| Authors: | Prince, H. M.; Bahlis, N. J.; Rodríguez-Otero, P.; Karlin, L.; Akard, L.; Varshavsky-Yanovsky, A.; Chu, M. P.; Nagai, Y.; Vesole, D. H.; Hickman, A.; Sullivan, S. T.; Leip, E.; Conte, U.; Viqueira, A.; Lesokhin, A. M. |
| Abstract Title: | MagnetisMM-3: Long-term update and efficacy and safety of less frequent dosing of elranatamab in patients with relapsed or refractory multiple myeloma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 4738 |
| End Page: | 4739 |
| Language: | English |
| ACCESSION: | WOS:001416739600042 |
| DOI: | 10.1182/blood-2024-208192 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
